Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy.

Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy. — المؤلف: Chu, Michael P — Journal of cachexia, sarcopenia and muscle 20180205

المؤلف
Chu, Michael P
النشر
Journal of cachexia, sarcopenia and muscle 20180205
الوصف
298-304 p.
الموضوعات
Adult؛ Aged؛ Aged, 80 and over؛ Antineoplastic Agents, Immunological؛ Female؛ Humans؛ Lymphoma, Large B-Cell, Diffuse؛ Male